Revealing on April 30: Are You Ready for the Upcoming Election Surprise?
Here is the latest financial fact sheet of ANUH PHARMA. For more details, see the ANUH PHARMA quarterly results and ANUH PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 3.6 |
No. of shares | m | 50.11 |
1 Week | % | 1.8 |
1 Month | % | -0.0 |
1 Year | % | 178.1 |
52 week H/L | Rs | 265.0/86.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ANUH PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 190 | 170 | 437 | 166 | 110 | |
Low | Rs | 119 | 97 | 90 | 85 | 77 | |
Sales per share (Unadj.) | Rs | 128.0 | 122.5 | 86.2 | 97.1 | 105.3 | |
Earnings per share (Unadj.) | Rs | 9.3 | 5.7 | 5.7 | 6.1 | 7.2 | |
Diluted earnings per share | Rs | 4.7 | 2.9 | 5.7 | 6.1 | 7.2 | |
Cash flow per share (Unadj.) | Rs | 10.0 | 8.5 | 8.7 | 8.5 | 9.2 | |
Dividends per share (Unadj.) | Rs | 2.75 | 2.75 | 1.50 | 1.75 | 2.00 | |
Adj. dividends per share | Rs | 1.38 | 1.38 | 1.50 | 1.75 | 2.00 | |
Avg Dividend yield | % | 1.8 | 2.1 | 0.6 | 1.4 | 2.1 | |
Book value per share (Unadj.) | Rs | 65.7 | 64.7 | 38.0 | 42.7 | 48.1 | |
Adj. book value per share | Rs | 32.8 | 32.4 | 38.0 | 42.7 | 48.1 | |
Shares outstanding (eoy) | m | 25.06 | 25.06 | 50.11 | 50.11 | 50.11 | |
Price / Sales ratio | x | 1.2 | 1.1 | 3.1 | 1.3 | 0.9 | |
Avg P/E ratio | x | 16.6 | 23.4 | 46.5 | 20.6 | 12.9 | |
P/CF ratio (eoy) | x | 15.5 | 15.7 | 30.4 | 14.8 | 10.2 | |
Price / Book Value ratio | x | 2.3 | 2.1 | 6.9 | 2.9 | 1.9 | |
Dividend payout | % | 29.5 | 48.2 | 26.4 | 28.7 | 27.7 | |
Avg Mkt Cap | Rs m | 3,868 | 3,345 | 13,215 | 6,290 | 4,683 | |
Total wages/salary | Rs m | 101 | 134 | 143 | 151 | 172 |
ANUH PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,207 | 3,070 | 4,320 | 4,866 | 5,275 | |
Other income | Rs m | 47 | 42 | 105 | 52 | 61 | |
Total revenues | Rs m | 3,254 | 3,112 | 4,425 | 4,918 | 5,336 | |
Gross profit | Rs m | 300 | 232 | 451 | 475 | 518 | |
Depreciation | Rs m | 17 | 70 | 151 | 120 | 97 | |
Interest | Rs m | 6 | 13 | 20 | 16 | 7 | |
Profit before tax | Rs m | 324 | 192 | 386 | 391 | 475 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 90 | 49 | 101 | 86 | 113 | |
Profit after tax | Rs m | 234 | 143 | 284 | 306 | 362 | |
Gross profit margin | % | 9.3 | 7.6 | 10.4 | 9.8 | 9.8 | |
Effective tax rate | % | 27.9 | 25.3 | 26.2 | 21.9 | 23.8 | |
Net profit margin | % | 7.3 | 4.7 | 6.6 | 6.3 | 6.9 |
ANUH PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,522 | 2,230 | 2,377 | 2,587 | 3,076 | |
Current liabilities | Rs m | 748 | 1,627 | 1,395 | 1,309 | 1,613 | |
Net working cap to sales | % | 24.1 | 19.6 | 22.7 | 26.3 | 27.7 | |
Current ratio | x | 2.0 | 1.4 | 1.7 | 2.0 | 1.9 | |
Inventory Days | Days | 46 | 101 | 29 | 36 | 66 | |
Debtors Days | Days | 848 | 964 | 903 | 1,018 | 1,185 | |
Net fixed assets | Rs m | 872 | 1,034 | 949 | 885 | 966 | |
Share capital | Rs m | 125 | 125 | 251 | 251 | 251 | |
"Free" reserves | Rs m | 1,521 | 1,497 | 1,656 | 1,887 | 2,162 | |
Net worth | Rs m | 1,646 | 1,622 | 1,906 | 2,138 | 2,412 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 2,394 | 3,264 | 3,326 | 3,472 | 4,042 | |
Interest coverage | x | 55.2 | 16.2 | 20.0 | 25.8 | 64.6 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.3 | 0.9 | 1.3 | 1.4 | 1.3 | |
Return on assets | % | 10.0 | 4.8 | 9.2 | 9.3 | 9.1 | |
Return on equity | % | 14.2 | 8.8 | 14.9 | 14.3 | 15.0 | |
Return on capital | % | 20.0 | 12.6 | 21.3 | 19.0 | 20.0 | |
Exports to sales | % | 46.2 | 46.4 | 49.2 | 44.3 | 52.5 | |
Imports to sales | % | 68.9 | 73.1 | 67.8 | 62.1 | 53.2 | |
Exports (fob) | Rs m | 1,481 | 1,424 | 2,125 | 2,156 | 2,770 | |
Imports (cif) | Rs m | 2,210 | 2,243 | 2,927 | 3,024 | 2,808 | |
Fx inflow | Rs m | 1,481 | 1,424 | 2,125 | 2,156 | 2,770 | |
Fx outflow | Rs m | 2,210 | 2,243 | 2,927 | 3,024 | 2,808 | |
Net fx | Rs m | -729 | -820 | -802 | -868 | -38 |
ANUH PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 71 | 489 | -187 | 289 | 539 | |
From Investments | Rs m | 29 | -765 | 522 | -78 | -435 | |
From Financial Activity | Rs m | -65 | 222 | -331 | -194 | -123 | |
Net Cashflow | Rs m | 35 | -54 | 4 | 16 | -19 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Arun Todarwal | COMP SEC: Ashwini Shrikant Ambrale | YEAR OF INC: 1960 | BSE CODE: 506260 | FV (Rs): 5 | DIV YIELD (%): 0.8 |
Read: ANUH PHARMA 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ANUH PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian stocks fell on Thursday as disappointing earnings forecasts from Facebook parent Meta Platforms hammered tech shares, while the yen's slump past 155 per dollar.